An open-labeled, multicentric clinical study of cetuximab combined with intensity-modulated radiotherapy (IMRT) plus concurrent chemotherapy in locoregionally advanced (LA) nasopharyngeal carcinoma (NPC): A 2-year follow-up report
第一作者机构：[1]Sun Yat Sen Univ, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China[2]Chinese Acad Med Sci, Canc Inst & Hosp, Beijing 100730, Peoples R China[3]Sichuan Canc Hosp, Chengdu, Peoples R China[4]Fujian Canc Hosp, Fuzhou, Peoples R China[5]Fudan Univ, Ctr Canc, Shanghai 200433, Peoples R China[6]Guizhou Canc Hosp, Guiyang, Peoples R China[7]Guangxi Med Univ, Affiliated Hosp 1, Nanning, Peoples R China[8]Wuhan Univ, Hubei Canc Clin Study Ctr, Wuhan 430072, Peoples R China[9]Wuhan Univ, Zhongnan Hosp, Wuhan 430072, Peoples R China[10]Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China
推荐引用方式(GB/T 7714)：
Chen Chun-yan,Zhao Chong,Gao Li,et al.An open-labeled, multicentric clinical study of cetuximab combined with intensity-modulated radiotherapy (IMRT) plus concurrent chemotherapy in locoregionally advanced (LA) nasopharyngeal carcinoma (NPC): A 2-year follow-up report[J].JOURNAL OF CLINICAL ONCOLOGY.2012,30(15):
APA：
Chen, Chun-yan,Zhao, Chong,Gao, Li,Lang, Jin-yi,Pan, Jian-ji...&Lu, Tai-xiang.(2012).An open-labeled, multicentric clinical study of cetuximab combined with intensity-modulated radiotherapy (IMRT) plus concurrent chemotherapy in locoregionally advanced (LA) nasopharyngeal carcinoma (NPC): A 2-year follow-up report.JOURNAL OF CLINICAL ONCOLOGY,30,(15)
MLA：
Chen, Chun-yan,et al."An open-labeled, multicentric clinical study of cetuximab combined with intensity-modulated radiotherapy (IMRT) plus concurrent chemotherapy in locoregionally advanced (LA) nasopharyngeal carcinoma (NPC): A 2-year follow-up report".JOURNAL OF CLINICAL ONCOLOGY 30..15(2012)
医学